Das kutane Lymphom beim Hund – Verwechslungsgefahr!

Das kutane Lymphom des Hundes ist sehr variabel in Bezug auf das klinische Erscheinungsbild, z. B. Verteilungsmuster, Pruritus und Prognose. Aufgrund dieser Heterogenität kann es zu Verwechslungen mit anderen Hauterkrankungen kommen wie der atopischen Dermatitis oder der Sarkoptesräude.

• Literatur

• 1 Fontaine J, Bovens C, Betteany S. et al. Canine cutaneous epitheliotropic T-cell lymphoma: a review. Vet Comp Oncol 2009; 7 (01) 1-14
• 2 Miller WH, Griffin CE, Campbell KL. Muller and Kirkʼs Small Animal Dermatology. 7^th ed. St. Louis, Missouri: Elsevier Saunders; 2012
• 3 Santoro D, Marsella R, Hernandez J. Investigation on the association between atopic dermatitis and the development of mycosis fungoides in dogs: a retrospective case-control study. Vet Dermatol 2007; 18 (02) 101-106
• 4 Kim EJ, Hess S, Richardson SK. et al. Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest 2005; 115 (04) 798-812
• 5 Thrall MA, Macy DW, Snyder SP. et al. Cutaneous lymphosarcoma and leukemia in a dog resembling Sézary syndrome in man. Vet Pathol 1984; 21 (02) 182-186
• 6 Fontaine J, Heimann M, Day MJ. Canine cutaneous epitheliotropic T-cell lymphoma: a review of 30 cases. Vet Dermatol 2010; 21 (03) 267-275
• 7 Fernandez NJ, West KH, Jackson ML. et al. Immunohistochemical and histochemical stains for differentiating canine cutaneous round cell tumors. Vet Pathol 2005; 42 (04) 437-445
• 8 Chaubert P, Baur Chaubert AS, Sattler U. et al. Improved polymerase chain reaction-based method to detect early-stage epitheliotropic T-cell lymphoma (mycosis fungoides) in formalin-fixed, paraffin-embedded skin biopsy specimens of the dog. J Vet Diagn Invest 2010; 22 (01) 20-29
• 9 Moore PF, Affolter VK, Keller SM. Canine inflamed nonepitheliotropic cutaneous T-cell lymphoma: a diagnostic conundrum. Vet Dermatol 2013; 24 (01) 204-211
• 10 Chan CM, Frimberger AE, Moore AS. Clinical outcome and prognosis of dogs with histopathological features consistent with epitheliotropic lymphoma: a retrospective study of 148 cases (2003–2015). Vet Dermatol 2018; 29 (02) 154-159
• 11 Santoro D, Kubicek L, LU B. et al. Total skin electron therapy as treatment for epitheliotropic lymphoma in a dog. Vet Dermatol 2017; 28 (02) 246-265
• 12 Laprais A, Olivry T. Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topic. BMC Vet Res 2017; 13 (01) 61
• 13 Heading KL, Brockley LK, Bennett PF. CCNU (lomustine) toxicity in dogs: a retrospective study (2002–07). Aust Vet J 2011; 89 (04) 109-116
• 14 Risbon RE, de Lorimier LP, Skorupski K. et al. Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): a retrospective study of 46 cases (1999–2004). J Vet Intern Med 2006; 20 (06) 1389-1397
• 15 Williams LE, Rassnick KW, Power HT. et al. CCNU in the treatment of canine epitheliotropic lymphoma. J Vet Intern Med 2006; 20 (01) 136-143
• 16 Holtermann N, Kiupel M, Kessler M. et al. Masitinib monotherapy in canine epitheliotropic lymphoma. Vet Comp Oncol 2016; 14 Suppl 1: 127-135
• 17 Iwamoto K, Bennett LR, Norman A. et al. Linoleate produces remission in canine mycosis fungoides. Cancer Lett 1992; 64 (01) 17-22
• 18 White SD, Rosychuck RA, Scott KV. et al. Use of isotretinoin and etretinate for the treatment of benign cutaneous neoplasia and cutaneous lymphoma in dogs. J Am Vet Med Assoc 1993; 202 (03) 387-391